Acetaminophen/Salicylamide/Phenylephrine Hydrochloride/Brompheniramine Maleate/Caffeine

对乙酰氨基酚/水杨酰胺/盐酸去氧肾上腺素/马来酸溴苯那敏/咖啡因

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAcetaminophen/Salicylamide/Phenylephrine Hydrochloride/Brompheniramine Maleate/Caffeine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsAdrenergic receptor alpha-1 agonistsHistamine H1 receptor antagonists +[5] 
TargetsCyclooxygenasesAdrenergic receptors alpha-1Histamine H1 receptor +[5] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AcetaminophenSalicylamidePhenylephrine Hydrochloride
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesAdvance Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdvance Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A